Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Injections, Intravenous"" wg kryterium: Temat


Tytuł :
Dilution is no solution.
Autorzy :
Deutsch L; Lynn Deutsch is a vascular access specialist for the Ascension Seton Hospital System in Austin, Tex., an adjunct professor of nursing for Austin Community College, and president of the Infusion Nurses Society (2019-2020).
Pokaż więcej
Źródło :
Nursing [Nursing] 2020 May; Vol. 50 (5), pp. 61-62.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Therapy/*nursing
Injections, Intravenous/*nursing
Medication Errors/*nursing
Humans ; Injections, Intravenous/adverse effects ; Injections, Intravenous/methods ; Medication Errors/statistics & numerical data ; Practice Guidelines as Topic ; Practice Patterns, Nurses'/standards
Czasopismo naukowe
Tytuł :
Distraction using virtual reality for children during intravenous injections in an emergency department: A randomised trial.
Autorzy :
Chen YJ; Department of Nursing, National Yang-Ming University Hospital, Yilan, Taiwan.; School of Nursing, National Yang-Ming University, Taipei, Taiwan.
Cheng SF; Department of Allied Health Education and Digital Learning, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
Lee PC; Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan.
Lai CH; Department of Nursing, National Yang-Ming University Hospital, Yilan, Taiwan.
Hou IC; School of Nursing, National Yang-Ming University, Taipei, Taiwan.
Chen CW; School of Nursing, National Yang-Ming University, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of clinical nursing [J Clin Nurs] 2020 Feb; Vol. 29 (3-4), pp. 503-510. Date of Electronic Publication: 2019 Dec 04.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Virtual Reality*
Injections, Intravenous/*psychology
Child ; Emergency Service, Hospital ; Fear ; Female ; Humans ; Injections, Intravenous/nursing ; Male ; Pain Management/methods ; Pain Measurement ; Time Factors
Czasopismo naukowe
Tytuł :
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Autorzy :
Urwyler P; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Charitos P; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Moser S; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Heijnen IAFM; Division of Medical Immunology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
Trendelenburg M; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research and Department of Biomedicine, University of Basel, Basel, Switzerland.
Thoma R; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Sumer J; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Camacho-Ortiz A; Hospital Universitario Dr. José Eleuterio González, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Bacci MR; Department of General Practice, Centro Universitário em Saúde do ABC, Santo André, SP, Brazil.
Huber LC; Clinic for Internal Medicine, City Hospital Triemli, Zurich, Switzerland.
Stüssi-Helbling M; Clinic for Internal Medicine, City Hospital Triemli, Zurich, Switzerland.
Albrich WC; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Sendi P; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Osthoff M; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland. .; Department of Clinical Research and Department of Biomedicine, University of Basel, Basel, Switzerland. .
Pokaż więcej
Źródło :
Trials [Trials] 2021 Jan 04; Vol. 22 (1), pp. 1. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji :
Clinical Trial Protocol; Letter
MeSH Terms :
COVID-19/*drug therapy
Complement C1 Inhibitor Protein/*administration & dosage
SARS-CoV-2/*isolation & purification
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Brazil ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/virology ; Clinical Trials, Phase II as Topic ; Complement C1 Inhibitor Protein/adverse effects ; Complement C1 Inhibitor Protein/pharmacokinetics ; Drug Administration Schedule ; Female ; Humans ; Injections, Intravenous/methods ; Male ; Mexico ; Middle Aged ; Multicenter Studies as Topic ; Pilot Projects ; Randomized Controlled Trials as Topic ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/adverse effects ; Recombinant Proteins/pharmacokinetics ; Severity of Illness Index ; Switzerland ; Treatment Outcome ; Young Adult
SCR Protocol :
COVID-19 drug treatment
Opinia redakcyjna
Tytuł :
Evaluation of the distribution of nicotine intravenous injection: an adult autopsy case report with a review of literature.
Autorzy :
Aoki Y; Department of Legal Medicine, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno, Osaka, 545-8585, Japan. .
Ikeda T; Department of Legal Medicine, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno, Osaka, 545-8585, Japan.; Forensic Autopsy Section, Medico-legal Consultation and Postmortem Investigation Support Center, c/o Department of Legal Medicine, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno, Osaka, 545-8585, Japan.
Tani N; Department of Legal Medicine, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno, Osaka, 545-8585, Japan.; Forensic Autopsy Section, Medico-legal Consultation and Postmortem Investigation Support Center, c/o Department of Legal Medicine, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno, Osaka, 545-8585, Japan.
Shida A; Department of Legal Medicine, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno, Osaka, 545-8585, Japan.
Oritani S; Department of Legal Medicine, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno, Osaka, 545-8585, Japan.
Ishikawa T; Department of Legal Medicine, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno, Osaka, 545-8585, Japan.; Forensic Autopsy Section, Medico-legal Consultation and Postmortem Investigation Support Center, c/o Department of Legal Medicine, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno, Osaka, 545-8585, Japan.
Pokaż więcej
Źródło :
International journal of legal medicine [Int J Legal Med] 2020 Jan; Vol. 134 (1), pp. 243-249. Date of Electronic Publication: 2019 Apr 07.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Injections, Intravenous*
Heart Arrest/*etiology
Nicotine/*poisoning
Autopsy ; Cotinine/metabolism ; Fatal Outcome ; Female ; Humans ; Pericardial Fluid/metabolism ; Peritoneal Absorption ; Tissue Distribution ; Young Adult
Czasopismo naukowe
Tytuł :
Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults.
Autorzy :
Lambert D; Department of Cardiovascular Sciences (Anaesthesia), University of Leicester, Leicester, UK. Electronic address: .
Calo G; Department of Biomedical and Specialty Surgical Sciences (Pharmacology), University of Ferrara, Ferrara, Italy.
Pokaż więcej
Źródło :
British journal of anaesthesia [Br J Anaesth] 2020 Dec; Vol. 125 (6), pp. e473-e474. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Letter
MeSH Terms :
Drug Approval*
Pain/*drug therapy
Spiro Compounds/*therapeutic use
Thiophenes/*therapeutic use
Humans ; Injections, Intravenous ; Spiro Compounds/adverse effects ; Thiophenes/adverse effects
Opinia redakcyjna
Tytuł :
Hydrous icaritin nanorods with excellent stability improves the in vitro and in vivo activity against breast cancer.
Autorzy :
Wang Y; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China.
Huang T; School of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, PR China.
Li H; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China.
Fu J; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China.
Ao H; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China.
Lu L; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China.
Han M; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China.
Guo Y; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China.
Yue F; Guangdong Jiabo Pharmaceutical Co. Ltd., Guangdong, PR China.
Wang X; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China.
Pokaż więcej
Źródło :
Drug delivery [Drug Deliv] 2020 Dec; Vol. 27 (1), pp. 228-237.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Nanotubes*
Antineoplastic Agents, Phytogenic/*pharmacology
Breast Neoplasms/*drug therapy
Flavonoids/*pharmacology
Animals ; Antineoplastic Agents, Phytogenic/administration & dosage ; Drug Stability ; Female ; Flavonoids/administration & dosage ; Humans ; Injections, Intravenous ; MCF-7 Cells ; Mice ; Mice, Nude ; Paclitaxel/administration & dosage ; Paclitaxel/pharmacology ; Particle Size
Czasopismo naukowe
Tytuł :
Thrombolysis and bridging therapy in patients with acute ischaemic stroke and Covid-19.
Autorzy :
Cappellari M; Stroke Unit, Department of Neuroscience, Azienda Ospedaliera Universitaria Integrata, Verona.
Zini A; IRCCS Istituto di Scienze Neurologiche di Bologna, Department of Neurology and Stroke Center, Maggiore Hospital, Bologna.
Sangalli D; UO di Neurologia-Stroke Unit, Ospedale Alessandro Manzoni-ASST, Lecco.
Cavallini A; UC Malattie Cerebrovascolari-Stroke Unit, IRCCS Fondazione Mondino, Pavia.
Reggiani M; Neurologia, ASLTO3, Rivoli.
Sepe FN; Stroke Unit-Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria.
Rifino N; Stroke Unit, Ospedale Papa Giovanni XXIII, Bergamo.
Giussani G; Neurologia-Stroke Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan.
Guidetti D; U.O.C. Neurologia, Ospedale Guglielmo da Saliceto, Piacenza.
Zedde M; Patologia Cerebrovascolare-Stroke Unit, Arcispedale Santa Maria Nuova, Reggio Emilia.
Marcheselli S; Sezione Autonoma di Neurologia d'Urgenza e Stroke Unit Humanitas Research Hospital, Rozzano.
Longoni M; Neurologia-Stroke Unit, Ospedale M. Bufalini-AUSL Romagna, Cesana.
Beretta S; Department of Neurology and Stroke Unit, San Gerardo Hospital, ASST Monza, Monza.
Sidoti V; UOS Stroke Unit, ASST Franciacorta, Chiari.
Papurello DM; Neurologia, ASLTO4, Ciriè.
Giossi A; UO Neurologia-ASST Cremona.
Nencini P; SOD Stroke Unit, Dipartimento DEA, AOU Careggi, Florence.
Plocco M; Stroke Unit, F. Spaziani, Frosinone.
Balestrino M; Centro Ictus, Ospedale Policlinico San Martino, Genoa.
Rota E; Neurologia, Ospedale S. Giacomo, Novi Ligure.
Toni D; Department of Human Neurosciences, Sapienza University, Rome, Italy.
Pokaż więcej
Źródło :
European journal of neurology [Eur J Neurol] 2020 Dec; Vol. 27 (12), pp. 2641-2645. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19/*complications
COVID-19/*therapy
Ischemic Stroke/*complications
Ischemic Stroke/*therapy
Thrombolytic Therapy/*methods
Aged ; Aged, 80 and over ; Blood Glucose/analysis ; COVID-19/mortality ; Cause of Death ; Creatinine/blood ; Female ; Fibrinolytic Agents/administration & dosage ; Fibrinolytic Agents/therapeutic use ; Humans ; Injections, Intravenous ; Ischemic Stroke/mortality ; Italy/epidemiology ; Male ; Pandemics ; Survival Analysis ; Thrombectomy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs.
Autorzy :
Wu J; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Zhou X; Wuhan Jinyintan Hospital, Wuhan, China.
Tan Y; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.
Wang L; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; University of Chinese Academy of Sciences, Beijing, China.
Li T; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Li Z; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Gao T; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; University of Chinese Academy of Sciences, Beijing, China.
Fan J; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.
Guo B; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; University of Chinese Academy of Sciences, Beijing, China.
Li W; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; University of Chinese Academy of Sciences, Beijing, China.
Hao J; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Wang X; Wuhan Jinyintan Hospital, Wuhan, China.
Hu B; Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; University of Chinese Academy of Sciences, Beijing, China.
Pokaż więcej
Źródło :
Cell proliferation [Cell Prolif] 2020 Dec; Vol. 53 (12), pp. e12944. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji :
Clinical Trial, Phase I; Letter
MeSH Terms :
COVID-19/*pathology
Human Embryonic Stem Cells/*cytology
Pulmonary Fibrosis/*therapy
T-Lymphocytes, Regulatory/*transplantation
Adult ; Aged ; COVID-19/complications ; COVID-19/virology ; Cell Differentiation ; Female ; Human Embryonic Stem Cells/metabolism ; Humans ; Injections, Intravenous ; Male ; Middle Aged ; Pulmonary Fibrosis/etiology ; SARS-CoV-2/isolation & purification ; T-Lymphocytes, Regulatory/cytology ; T-Lymphocytes, Regulatory/metabolism
Raport
Tytuł :
Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY.
Autorzy :
Nishio M; The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Seto T; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Reck M; LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
Garon EB; David Geffen School of Medicine at UCLA/TRIO-US Network, Los Angeles, CA, USA.
Chiu CH; Taipei Veterans General Hospital, Taipei, Taiwan.
Yoh K; National Cancer Center Hospital East, Kashiwa, Japan.
Imamura F; Osaka International Cancer Institute, Osaka, Japan.
Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shih JY; National Taiwan University Hospital, Taipei, Taiwan.
Visseren-Grul C; Eli Lilly and Company, Utrecht, The Netherlands.
Frimodt-Moller B; Eli Lilly and Company, Copenhagen, Denmark.
Zimmermann A; Eli Lilly and Company, Indianapolis, IN, USA.
Homma G; Eli Lilly Japan KK, Kobe, Japan.
Enatsu S; Eli Lilly Japan KK, Kobe, Japan.
Nakagawa K; Kindai University Faculty of Medicine, Osaka, Japan.
Pokaż więcej
Corporate Authors :
RELAY Study Investigators
Źródło :
Cancer science [Cancer Sci] 2020 Dec; Vol. 111 (12), pp. 4510-4525. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Genes, erbB-1*
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Erlotinib Hydrochloride/*therapeutic use
Lung Neoplasms/*drug therapy
Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/secondary ; Erlotinib Hydrochloride/adverse effects ; Female ; Hong Kong ; Humans ; Injections, Intravenous ; Japan ; Lung Neoplasms/genetics ; Lung Neoplasms/mortality ; Male ; Middle Aged ; Mutation ; Placebos/therapeutic use ; Progression-Free Survival ; Republic of Korea ; Taiwan ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant Enterococcus faecium : A Focused Review of Linezolid and Daptomycin.
Autorzy :
Lee BJ; University of California Irvine Health, Orange, CA, USA.; University of Southern California, Los Angeles, CA, USA.
Vu BN; Rush University Medical Center, Chicago, IL, USA.; Chicago State University College of Pharmacy, Chicago, IL, USA.
Seddon AN; Rush University Medical Center, Chicago, IL, USA.; Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA.
Hodgson HA; Rush University Medical Center, Chicago, IL, USA.
Wang SK; Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA.; Northwestern Memorial Hospital, Chicago, IL, USA.
Pokaż więcej
Źródło :
The Annals of pharmacotherapy [Ann Pharmacother] 2020 Dec; Vol. 54 (12), pp. 1243-1251. Date of Electronic Publication: 2020 Jun 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Central Nervous System Infections/*drug therapy
Daptomycin/*therapeutic use
Enterococcus faecium/*drug effects
Linezolid/*therapeutic use
Vancomycin-Resistant Enterococci/*drug effects
Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/pharmacokinetics ; Central Nervous System Infections/microbiology ; Daptomycin/adverse effects ; Daptomycin/pharmacokinetics ; Drug Monitoring ; Humans ; Injections, Intravenous ; Injections, Spinal ; Linezolid/adverse effects ; Linezolid/pharmacokinetics ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinical characteristics and treatment effects of astragalus injection in non-pediatric patients with acute fulminant myocarditis.
Autorzy :
Yang H; Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Lu Y
Yang H
Yuan J
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Nov 25; Vol. 99 (48), pp. e23062.
Typ publikacji :
Journal Article
MeSH Terms :
Astragalus Plant*
Antiviral Agents/*therapeutic use
Drugs, Chinese Herbal/*therapeutic use
Myocarditis/*drug therapy
Plant Extracts/*therapeutic use
Adolescent ; Adult ; Aged ; Antiviral Agents/administration & dosage ; Drugs, Chinese Herbal/administration & dosage ; Female ; Humans ; Injections, Intravenous ; Male ; Middle Aged ; Myocarditis/mortality ; Phytotherapy ; Plant Extracts/administration & dosage ; Retrospective Studies ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour.
Autorzy :
Oladapo OT; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Okusanya BO; Experimental and Maternal Medicine Unit, Department of Obstetrics and Gynaecology, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria.
Abalos E; Centro Rosarino de Estudios Perinatales (CREP), Rosario, Argentina.
Gallos ID; Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Papadopoulou A; Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Nov 09; Vol. 11. Cochrane AN: CD009332. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Labor Stage, Third*
Oxytocics/*administration & dosage
Oxytocin/*administration & dosage
Postpartum Hemorrhage/*prevention & control
Bias ; Blood Transfusion/statistics & numerical data ; Confidence Intervals ; Female ; Humans ; Injections, Intramuscular ; Injections, Intravenous ; Oxytocics/adverse effects ; Oxytocin/adverse effects ; Postpartum Hemorrhage/epidemiology ; Pregnancy ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model.
Autorzy :
Yano J; Center for Oral and Craniofacial Biology, Louisiana State University Health-School of Dentistry.
Lilly EA; Department of Microbiology and Immunology, Tulane University School of Medicine.
Noverr MC; Department of Microbiology and Immunology, Tulane University School of Medicine.
Fidel PL; Center for Oral and Craniofacial Biology, Louisiana State University Health-School of Dentistry; .
Pokaż więcej
Źródło :
Journal of visualized experiments : JoVE [J Vis Exp] 2020 Nov 06 (165). Date of Electronic Publication: 2020 Nov 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Video-Audio Media
MeSH Terms :
Hot Temperature*
Injections/*instrumentation
Sepsis/*microbiology
Tail/*blood supply
Veins/*pathology
Animals ; Candida/immunology ; Disease Models, Animal ; Fungal Vaccines/immunology ; Injections, Intravenous ; Mice, Inbred C57BL ; Needles ; Rats ; Sepsis/complications ; Vaccination
Czasopismo naukowe
Tytuł :
Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease.
Autorzy :
Truffi M; Nanomedicine and Molecular Imaging Laboratory, Istituti Clinici Scientifici Maugeri IRCCS, Pavia 27100, Italy.
Sevieri M; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.
Morelli L; NanoBioLab, Department of Biotechnology and Biosciences, Università degli studi di Milano-Bicocca, Milano, 20126, Italy.
Monieri M; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.
Mazzucchelli S; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.
Sorrentino L; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.
Allevi R; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.
Bonizzi A; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.
Zerbi P; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.
Marchini B; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.
Longhi E; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.
Sampietro GM; IBD Surgery Unit, ASST Fatebenefratelli Sacco - Ospedale 'Luigi Sacco' Polo Universitario, Milano, 20157, Italy.
Colombo F; IBD Surgery Unit, ASST Fatebenefratelli Sacco - Ospedale 'Luigi Sacco' Polo Universitario, Milano, 20157, Italy.
Prosperi D; NanoBioLab, Department of Biotechnology and Biosciences, Università degli studi di Milano-Bicocca, Milano, 20126, Italy.
Colombo M; NanoBioLab, Department of Biotechnology and Biosciences, Università degli studi di Milano-Bicocca, Milano, 20126, Italy.
Corsi F; Department of Biomedical and Clinical Sciences 'Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.; Surgery Department, Breast Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, 27100, Italy.
Pokaż więcej
Źródło :
International journal of nanomedicine [Int J Nanomedicine] 2020 Nov 02; Vol. 15, pp. 8537-8552. Date of Electronic Publication: 2020 Nov 02 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Cell Adhesion Molecules/*immunology
Immunoconjugates/*administration & dosage
Inflammatory Bowel Diseases/*diagnostic imaging
Mucoproteins/*immunology
Quantum Dots/*administration & dosage
Animals ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/immunology ; Colitis/chemically induced ; Colitis/diagnostic imaging ; Crohn Disease/diagnostic imaging ; Disease Models, Animal ; Female ; Humans ; Immunoconjugates/pharmacokinetics ; Injections, Intravenous ; Intestinal Mucosa/diagnostic imaging ; Intestines/diagnostic imaging ; Magnetic Resonance Imaging/methods ; Mice, Inbred C57BL ; Nanoparticles/administration & dosage ; Nanoparticles/chemistry ; Polyesters/chemistry ; Polyethylene Glycols/chemistry ; Tissue Distribution
Czasopismo naukowe
Tytuł :
The Median Effective Dose of One Intravenous Bolus of Oxycodone for Postoperative Analgesia After Myomectomy and Hysterectomy With Local Ropivacaine Wound Infiltration: An Up-Down Dose-Finding Study.
Autorzy :
Yu W; From the Department of Anesthesiology of Shengjing Hospital, China Medical University, Shenyang, China.
Wu X
Liu L
Long B
Tian Y
Ma C
Dong Y
Pokaż więcej
Źródło :
Anesthesia and analgesia [Anesth Analg] 2020 Nov; Vol. 131 (5), pp. 1599-1606.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Analgesics, Opioid/*administration & dosage
Analgesics, Opioid/*therapeutic use
Anesthetics, Local/*therapeutic use
Hysterectomy/*adverse effects
Oxycodone/*administration & dosage
Oxycodone/*therapeutic use
Pain, Postoperative/*drug therapy
Ropivacaine/*therapeutic use
Uterine Myomectomy/*adverse effects
Adult ; Anesthesia, Local ; Anesthetics, Local/administration & dosage ; Blood Pressure/drug effects ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Heart Rate/drug effects ; Humans ; Injections, Intravenous ; Laparoscopy ; Middle Aged ; Pain Measurement ; Prospective Studies ; Ropivacaine/administration & dosage
Czasopismo naukowe
Tytuł :
Pharmacokinetics of hydromorphone hydrochloride after intramuscular and intravenous administration of a single dose to orange-winged Amazon parrots ( Amazona amazonica ).
Autorzy :
Sanchez-Migallon Guzman D
Knych H
Douglas J
Paul-Murphy JR
Pokaż więcej
Źródło :
American journal of veterinary research [Am J Vet Res] 2020 Nov; Vol. 81 (11), pp. 894-898.
Typ publikacji :
Journal Article
MeSH Terms :
Amazona*
Hydromorphone*
Administration, Intravenous/veterinary ; Analgesics, Opioid ; Animals ; Area Under Curve ; Cross-Over Studies ; Female ; Half-Life ; Injections, Intramuscular/veterinary ; Injections, Intravenous/veterinary ; Male
Czasopismo naukowe
Tytuł :
Brentuximab vedotin plus nivolumab as first-line therapy in older or chemotherapy-ineligible patients with Hodgkin lymphoma (ACCRU): a multicentre, single-arm, phase 2 trial.
Autorzy :
Cheson BD; Lymphoma Research Foundation, New York, NY, USA. Electronic address: .
Bartlett NL; Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, USA.
LaPlant B; Division of Biomedical Statistics and Bioinformatics, Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, MN, USA.
Lee HJ; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
Advani RJ; Stanford Cancer Institute, Stanford, CA, USA.
Christian B; Hematology Division, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Diefenbach CS; Clinical Lymphoma Program, Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA.
Feldman TA; Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, USA.
Ansell SM; Division of Medical Oncology, Department of Medicine, Mayo Clinic Rochester, Rochester, MN, USA.
Pokaż więcej
Źródło :
The Lancet. Haematology [Lancet Haematol] 2020 Nov; Vol. 7 (11), pp. e808-e815. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study
MeSH Terms :
Antineoplastic Agents, Immunological/*therapeutic use
Brentuximab Vedotin/*therapeutic use
Hodgkin Disease/*drug therapy
Nivolumab/*therapeutic use
Aged ; Antineoplastic Agents, Immunological/adverse effects ; Brentuximab Vedotin/adverse effects ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Hematologic Diseases/diagnosis ; Hematologic Diseases/etiology ; Hodgkin Disease/mortality ; Hodgkin Disease/pathology ; Humans ; Injections, Intravenous ; Male ; Middle Aged ; Nivolumab/adverse effects ; Peripheral Nervous System Diseases/diagnosis ; Peripheral Nervous System Diseases/etiology ; Progression-Free Survival ; Remission Induction ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study.
Autorzy :
Pezel T; Inserm, UMRS 942, Department of Cardiology, Lariboisière Hospital, Paris University, AP-HP, 75010 Paris, France; Division of Cardiology, Johns-Hopkins University, 21287-0409 Baltimore, MD, USA.
Besseyre des Horts T; Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France.
Schaaf M; Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France.
Croisille P; Radiology Department, University Hospital of Saint-Étienne, 42270 Saint-Priest-en-Jarez, France.
Bière L; Cardiology Division, University Hospital of Angers, 49100 Angers, France.
Garcia-Dorado D; CIBERCV, Hospital Universitari Vall d'Hebron & Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Jossan C; Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France.
Roubille F; UMR5203, UMR661, Cardiology Division, University Hospital of Montpellier, University of Montpellier 1 and 2, 34295 Montpellier, France.
Cung TT; UMR5203, UMR661, Cardiology Division, University Hospital of Montpellier, University of Montpellier 1 and 2, 34295 Montpellier, France.
Prunier F; Cardiology Division, University Hospital of Angers, 49100 Angers, France.
Meyer E; Rangeuil Hospital, University Hospital of Toulouse, Paul-Sabatier University, 31400 Toulouse, France.
Amaz C; Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France.
Derumeaux G; DHU-ATVB, Henri-Mondor Hospital, Paris-Est Créteil University, AP-HP, 94010 Créteil, France.
de Poli F; Cardiology Division, Haguenau Hospital, 67500 Haguenau, France.
Hovasse T; Cardiology Division, Jacques-Cartier Institute, 91300 Massy, France.
Gilard M; Department of Cardiology, Brest University Hospital, 29200 Brest, France.
Bergerot C; Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France.
Thibault H; Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France.
Ovize M; Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France.
Mewton N; Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France. Electronic address: .
Pokaż więcej
Źródło :
Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2020 Nov; Vol. 113 (11), pp. 710-720. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Magnetic Resonance Imaging, Cine*
Ventricular Function, Left*
Ventricular Remodeling*
Anterior Wall Myocardial Infarction/*diagnostic imaging
ST Elevation Myocardial Infarction/*diagnostic imaging
Aged ; Anterior Wall Myocardial Infarction/mortality ; Anterior Wall Myocardial Infarction/physiopathology ; Anterior Wall Myocardial Infarction/therapy ; Cyclosporine/administration & dosage ; Double-Blind Method ; Early Diagnosis ; Female ; France ; Heart Disease Risk Factors ; Humans ; Injections, Intravenous ; Male ; Middle Aged ; Percutaneous Coronary Intervention ; Predictive Value of Tests ; Risk Assessment ; ST Elevation Myocardial Infarction/mortality ; ST Elevation Myocardial Infarction/physiopathology ; ST Elevation Myocardial Infarction/therapy ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Comparative pharmacokinetics of intravenous and intramuscular cefquinome sulfate administration in ducklings and goslings.
Autorzy :
Cheng P
Feng T
Zhang Y
Li X
Tian L
Wu J
Cheng F
Zeng Y
Chen H
He X
Fu G
Zheng L
Chen H
Pokaż więcej
Źródło :
American journal of veterinary research [Am J Vet Res] 2020 Nov; Vol. 81 (11), pp. 837-877.
Typ publikacji :
Journal Article
MeSH Terms :
Ducks*
Geese*
Animals ; Anti-Bacterial Agents ; Area Under Curve ; Biological Availability ; Cephalosporins ; Half-Life ; Injections, Intramuscular/veterinary ; Injections, Intravenous/veterinary ; Sulfates
Czasopismo naukowe
Tytuł :
Effects of perioperative magnesium sulfate with controlled hypotension on intraoperative bleeding and postoperative ecchymosis and edema in open rhinoplasty.
Autorzy :
Kosucu M; Medical School of Karadeniz Technical University, Department of Anesthesiology, 61080 Trabzon, Turkey. Electronic address: .
Tugcugil E; Medical School of Karadeniz Technical University, Department of Anesthesiology, 61080 Trabzon, Turkey.
Arslan E; Medical School of Karadeniz Technical University, Department of Neurosurgery, 61080 Trabzon, Turkey.
Omur S; Medical School of Karadeniz Technical University, Department of Anesthesiology, 61080 Trabzon, Turkey.
Livaoglu M; Medical School of Karadeniz Technical University, Department of Plastic and Reconstructive Surgery, 61080 Trabzon, Turkey.
Pokaż więcej
Źródło :
American journal of otolaryngology [Am J Otolaryngol] 2020 Nov - Dec; Vol. 41 (6), pp. 102722. Date of Electronic Publication: 2020 Sep 14.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Anesthesia/*methods
Blood Loss, Surgical/*prevention & control
Ecchymosis/*prevention & control
Edema/*prevention & control
Eyelid Diseases/*prevention & control
Hypotension, Controlled/*methods
Intraoperative Complications/*prevention & control
Magnesium Sulfate/*administration & dosage
Nose/*surgery
Perioperative Care/*methods
Postoperative Complications/*prevention & control
Rhinoplasty/*adverse effects
Adult ; Double-Blind Method ; Edema/etiology ; Eyelid Diseases/etiology ; Female ; Humans ; Infusions, Intravenous ; Injections, Intravenous ; Intraoperative Complications/etiology ; Male ; Middle Aged ; Postoperative Complications/etiology ; Postoperative Nausea and Vomiting/etiology ; Postoperative Nausea and Vomiting/prevention & control ; Rhinoplasty/methods
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies